Phase II Trial of RC1416 Injection in Asthma

NCT07403487 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Asthma

Interventions

DRUG: RC1416
DRUG: RC1416 Placebo

Sponsor

Nanjing RegeneCore Biotech Co., Ltd.